Heidelberg Pharma AG Financial Overview
Heidelberg Pharma AG's market cap is currently €132.40M. The company's EPS TTM is €-0.143; its P/E ratio is -5.04; Heidelberg Pharma AG is scheduled to report earnings on July 10, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
